EDITORIAL article
Front. Immunol.
Sec. Cytokines and Soluble Mediators in Immunity
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1713006
This article is part of the Research TopicCytokines, and biomarkers involved in the immunomodulation of pediatric cancersView all 5 articles
Editorial: Cytokines, and biomarkers involved in the immunomodulation of pediatric cancers
Provisionally accepted
- 1Integrated Oncologic Therapies, San Martino Hospital (IRCCS), Genova, Genoa, Italy
- 23Department of Paediatric Haematology, Oncology and Stem Cell Transplantation, University Hospital of Würzburg, Wurzburg, Germany
- 3Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Keywords: pediatric cancer, Tumor Microenvironment, Neuroblastoma, IGF1/IGF1R axis, immune response
Received: 25 Sep 2025; Accepted: 02 Oct 2025.
Copyright: © 2025 Poggi, Pietra, Caruana, Mariotti and Azzarone. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Alessandro Poggi, sandropoggi59@hotmail.it
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.